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Abstract
Background: Continuous positive airway pressure (CPAP) is typically recommended as first line therapy for
obstructive sleep apnea, but the adherence rate of CPAP is problematic. This study’s objective was to systematically
review the literature relating to CPAP as first line therapy for OSA and compare it to surgical literature on the same
topic.
Methods: A systematic review was conducted according to PRISMA guidelines, examining Medline-Ovid, Embase,
and Pubmed databases. The primary search objective was to identify all papers reporting the results of (1)
randomized clinical trials (RCT) of CPAP for the treatment of adults with OSA; and (2) both randomized and
non-randomized clinical trials and case series on the surgical treatment of OSA in adults. A PhD-level biostatistician
first screened papers, and then those that met study criteria were retrieved and analyzed using standardized forms
for each author. The primary outcomes were adherence rates of CPAP.
Results: A total of 82 controlled clinical trials for CPAP and 69 controlled and non-controlled surgery trials were
identified for analysis. Variation in CPAP use within reported RCT trials were identified, and the majority of patients
in the studies would eventually be considered non-adherent to CPAP.
Conclusions: When considering the numerous patient-related factors that come into play when CPAP is
prescribed, the concept of CPAP as gold-standard therapy for OSA should be reconsidered. In many cases surgery
can provide a better overall outcome. This study’s results suggest that certain patients with OSA may be managed
more effectively with surgery than CPAP, without confounding issues of treatment adherence.
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Background
Obstructive sleep apnea (OSA) is considered part of a
group of disorders that cover a continuum ranging from
habitual snoring (simple snoring) to moderate or severe
OSAS. OSA is characterized by repetitive apnea and/or
hypopnea during sleep. Due to relaxation of the upper
airway pharyngeal and tongue muscles during sleep the
airway narrows and collapses resulting in hypoxaemia,
increased sympathetic overdrive, increased blood pres-
sure, and hypercapnia. These add hypoxic stress to the
brain and heart. Apneic and hypopneic events may occur
numerous times per night, resulting in arousals from
sleep and sleep disruptions causing sleep fragmentation
leading to excessive daytime sleepiness. These repeated
cyclic oxygen desaturations and a fragmented sleep
architecture lead to sympathetic overdrive, interrupted
sleep, and reduced percentage of slow wave sleep, trans-
lating into symptoms of daytime somnolence, morning
headaches, poor concentration, memory loss, a higher
risk of car accidents, depression and marital discord.
OSA has a strong association with hypertension, ath-
erosclerosis, and cerebrovascular accidents (strokes) [1].
Studies have also shown a higher mortality rate among
patients with cardiovascular disease who also have OSA
[1]. It has been long purported that nasal continuous
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positive airway pressure (CPAP) is the “gold” standard in
the treatment of OSA, and there is no doubt that CPAP
is effective when used properly and according to AASM
standards. However, it is also well known that due to
problematic patient adherence, the real world effective-
ness of CPAP is low, with a large proportion of users
abandoning the machine within one year of prescription.
Such patients cannot be said to be effectively treated.
Surgery for OSA on the other hand does not rely on any
form of long-term patient adherence, and when the right
patient is matched with the right pharyngeal procedure
in order to maximize success, long-term strong results
have been shown. When considering all OSA patients it
is recognized that overall treatment success rates with
surgery are lower than via CPAP, but this does not hold
true for the subset of patients with appropriate apnea-
specific surgical anatomy wherein rates of successful sur-
gical OSA treatment are very high. Moreover the issue
of CPAP adherence has generally not been examined
during these debates; to make an effective comparison
adherence must be taken into account when studying
the impact on OSA of CPAP versus surgery. CPAP, an
efficacious therapy with inconsistent adherence, can po-
tentially be equivalent to surgery, that being a “partial”
therapy with complete adherence. It is the issue of treat-
ment effectiveness versus adherence (the relationship of
the two defining success) that is at the crux of the
matter.
This study’s objective was to systematically review the
literature relating to CPAP as first line therapy for OSA
and then compare it to surgical literature on the same
topic.
Methods
Our review was carried out in accordance with the pre-
ferred reporting items for systematic review and meta-
analysis protocols (PRISMA-P) 2015 statement. A
comprehensive systematic literature review was con-
ducted using the Medline-Ovid, Embase, and Pubmed
databases.
The primary search objective was to identify all papers
reporting the results of (1) randomized clinical trials
(RCT) of CPAP for the treatment of adults with OSA;
and (2) both randomized and non-randomized clinical
trials and case series on the surgical treatment of OSA
in adults. The first step was a locate and review all of
the studies listed for analysis in three major literature re-
views, a Cochrane Collaboration review [1] and a second
systematic literature review published by the National
Institutes of Health Research (NIHR) [2] on the use of
CPAP for the treatment of OSA, and a second Cochrane
Collaboration review on its surgical management [3].
The second step was an extensive search of the
PubMed/MedLine database, initiated using the following
combined search terms: “randomized clinical trial and
obstructive sleep apnea” (n = 1083); “CPAP and random-
ized clinical trial and obstructive sleep apnea” (n = 357);
and “surgery and obstructive sleep apnea and clinical
trial” (n = 603). From these lists, studies were identified
that (a) did not replicate studies already found and (b)
were otherwise eligible for inclusion. The third and final
step was a review of all reference lists and tables of other
studies found within papers identified in the second step.
A PhD level biostatistician performed all three of the
search steps.
Articles were considered for inclusion into the study
by reviewing the titles and abstracts of all retrieved stud-
ies. The senior study authors BWR and KPP did this and
results were compiled to ensure no studies were missed.
The full text of selected studies were then analyzed to
ensure that the following inclusion criteria were met:
diagnosis of obstructive sleep apnea, no confounding
data for central sleep apnea, and the paper referred to
either CPAP or surgical treatment of OSA.
Results
A total of 82 controlled clinical trials for CPAP and 69
controlled and non-controlled surgery trials were identi-
fied for analysis (note that non-controlled trials were ac-
cepted for surgery because of the relatively few controlled
trials). The CPAP studies included trials comparing CPAP
versus sub-therapeutic (sham) CPAP [4–34], CPAP versus
an oral placebo [33, 35–43], CPAP versus conservative or
no therapy [10, 22, 44–54], CPAP versus an oral appliance
[4, 5, 36, 51, 55–63], CPAP versus postural therapy
[64–67], and CPAP alone assessing different means to
modify adherence (e.g., with vs. without a humidifying
element) [8, 21, 30, 68–79]. The surgical trials assessed
a variety of single- and multi-stage procedures incorporat-
ing uvuloplasty [22, 80–117], mandibular advancement
[118, 119], laser treatments [120–125], radiofrequency tis-
sue reduction and other lingual procedures [117, 125–134],
and palate implants [135–141], in addition to five trials
specifically evaluating the safety versus risks of OSA sur-
gery, including its safety as an outpatient/same-day pro-
cedure [142–146]. The PRISMA charts seen in Figs. 1 and
2 summarize the study flow, and Additional files 1, 2, and
Table 1 summarize the results of the search strategy.
Discussion of findings
Currently, continuous positive airway pressure (CPAP) is
considered the gold standard treatment for patients with
obstructive sleep apnea, be it mild, moderate or severe.
This is the conclusion expressed in both a recently-pub-
lished Cochrane Collaboration review [1] and a second
systematic literature review published by the National
Institutes of Health Research (NIHR) [2]. Surgical ap-
proaches are hardly discussed at all in either of these two
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reviews, largely on the basis of the lack of randomized
controlled trials (RCTs). A closer look at the evidence
however reveals that surgery may indeed play a primary
role in many patients with OSA.
First, although a large number of RCTs have been
published documenting the benefits of CPAP relative to
sub-therapeutic (sham) CPAP [3–33], an oral placebo
[32, 34–43], conservative or no therapy [9, 21, 42, 44–53],
various oral appliances [3, 4, 35, 50, 54–62], and pos-
tural therapy [63–66], numerous limitations of these
RCTs must be considered. First among these is the short
duration of follow-up that has been almost ubiquitous
amongst CPAP trials, the vast majority having final as-
sessments within weeks of the initial treatment, and
only a small handful extending beyond 3 to 4 months
[46, 56], 6 months [3, 52], 1 year [9, 21], or beyond [44].
A couple of additional long-term cohort studies emerged
from RCT, following patients, open label, to and beyond
1 year [3, 62]. This contrasts, however, with the much
more long-term follow-up generally performed for surgi-
cal trials, where follow-up to and beyond 6 months is the
norm, with several investigative groups reporting on out-
comes beyond 1 year.
A second issue pertains to adherence with CPAP, a
well-documented problem that warrants concern. In our
review of 83 CPAP trials (Additional file 1), the average
patient in bed for 7 h across these 83 closely supervised
clinical trials was not using it an average of 32.9 % of the
time. When the nights per week of CPAP non-use have
been examined, the percentages range from 10 to 40 %
[5, 35, 50, 55, 67–70] These are problematic percentages
given that several published RCT have documented that
at least a minimum level of CPAP use of 5–6 h per night
is required to reap benefits from it [9, 37, 40, 68, 71].
There is therefore a sizeable subset of patients on CPAP
who either cease to use it altogether, or fail to use it
enough hours per night and/or nights per week to
achieve clinically-significant benefits.
The issue of adherence is generally a non-issue with
surgery, especially beyond the initial recovery period.
Once a patient’s anatomy is changed, it should remain
so. How effective is surgery? Admittedly, there are far
fewer EBM (evidence-based medicine) level 1 RCT and
many more EBM level 4 case series for OSA surgery, as
should be expected given the ethical and methodological
obstacles associated with performing double-blinded or
Fig. 1 PRISMA chart of CPAP study search strategy
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Fig. 2 PRISMA chart of surgery study search strategy







Treatment groups Study findings Study limitations/issues
Woodson
2003
1 RCT nCPAP vs. RFTR vs.
sham RFTR
Relative to sham Rx, rxn time & fastest rxn time both
improved post-RFTR (p = 0.03 & 0.02) but not on CPAP.
Very poor CPAP complance
(~16 h/week);
ESS ↓ similarly with RFTR & CPAP (−2.1 vs. −2.3,
p = 0.005 & 0.02). SNORE25 score ↓ w/both
(p < 0.001 vs. 0.005)
Different # of Rx sessions in
RFTR (4.5) vs. sham RFTR (2.9)
groups
Ceylan 2009 3 nonRCT TC-RFTR vs. nCPAP Both RFTR & CPAP→↓AHI (28.5→ 15.7 vs 29.6→ 16.1,
both p < 0.001; NS); ↓ESS (11.1→ 8.4,
p = 0.003 vs 10.8→ 8.2, p = 0.003; NS);
Non-random allocation to
Rx/potential selection bias;
↓CT90 (15.2→ 11.1 % vs 14.3→ 10.7 %,
both p < 0.001; NS); & ↑LSAT (88.4→ 93.5,
p = 0.03 vs 86.8→ 94.6 %, p < 0.001, NS). 53.8 vs. 52.4 %
responders






UPPP ± TE ± SP ±
other vs. CPAP
1339/18,754 (7.1 %) died w/ CPAP vs. 71/2072 (3.4 %)




MR ↑ 31 % (95 % CI 3–67 %) w/CPAP (p = 0.03) (e.g., severity of OSA, overall
health status)
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even controlled surgical trials. This being said, only 24
of the CPAP RCT described above were truly blinded,
pitting therapeutic CPAP against sub-therapeutic (and
thereby, sham) CPAP, rendering all comparisons, espe-
cially of subjective measures like the patient’s level of
sleepiness and quality of life, at least somewhat suspect.
Clearly, all subjects in these studies knew that they were
using an oral appliance, an oral placebo or nothing ver-
sus nasal CPAP. Interestingly, and harkening back to the
issue of adherence, though CPAP tended to improve ob-
jective measures of OSA to a greater degree than oral
appliances, patients consistently and decidedly preferred
the latter [35, 55, 57, 60].
The limitations of EBM level 4 evidence set aside,
among the 1802 patients who underwent OSA surgery
across the 53 studies we analyzed, more than half (957,
53.1 %) were deemed to have experienced a ‘good re-
sponse’. This is despite the consistent use of strict cri-
teria for a ‘response’ that ranged from Sher’s criteria of
no less than a 50 % reduction in AHI to a level of 20
events/hour or less [79], criteria that were used in 20 of
the studies [80–99]; to being as stringent as no less than
a 50 % reduction in RDI (which is similar to the AHI
but also incorporates near-hyponeic events) to a level of
20 events/hour or less [100–106]; no less than a 50 % re-
duction in either AHI or RDI (the latter also incorporat-
ing near-hyponeic events) to a level of 15 or even 10
events/hour or less [91, 107–110]; and reducing AHI or
RDI to ≤10 or even 5 events/hour [111–114] (Additional
file 2). Mandibular/maxillo-mandibular advancement
procedures had an especially high success (good re-
sponse) rate of 87.0 % [84, 107, 115]. Moreover, there
appeared to be a dose–response effect, with more ag-
gressive procedures incorporating UPPP more effective
than less aggressive procedures like tongue tissue ablation
(Additional file 2), and more repetitions of treatments like
laser- or radiofrequency- aided tissue reduction more
effective than fewer repetitions [116].
Only three studies directly have compared CPAP and
OSA surgery: one a randomized clinical trial comparing
therapeutic radiofrequency-aided tissue reduction (RFTR),
sham RFTR and nasal CPAP [117]; one a non-randomized
clinical trial comparing RFTR and nasal CPAP [83]; and
the third a population survey assessing long-term mortal-
ity among over 20,000 U.S. veterans who underwent either
UPPP or CPAP therapy between October 1997 and
September 2001 within the Veterans Affairs hospital
system [118]. These results are summarized in Table 1.
With the first study [117], subjective sleepiness, as
measured with the Epworth Sleepiness scale (ESS), de-
creased to the same extent with RFTR & CPAP (−2.1
vs. −2.3, p = 0.005 & 0.02), as did the patients’ level of
snoring, as measured with the SNORE25 (p < 0.001 vs.
0.005), both effects superior to sham RFTR (p < 0.001).
However, objective sleepiness, measured as each pa-
tient’s average and shortest reaction time, only im-
proved with RFTR (p = 0.03 and p = 0.02 versus sham
therapy, respectively). In the non-randomized trial
[83], RFTR and CPAP significantly reduced AHI versus
baseline (28.5→ 15.7 vs. 29.6→ 16.1, both p < 0.001;
no significant inter-treatment difference), with similar
significant reductions noted for the ESS score (11.1→
8.4, p = 0.003 vs. 10.8→ 8.2, p = 0.003; NS) and the per-
centage of time with oxygen saturation below 90 %
(15.2→ 11.1 % vs. 14.3→ 10.7 %, both p < 0.001; NS).
The two treatments also produced a similar increase in
the patient’s lowest recorded nocturnal oxygen saturation
level (88.4→ 93.5, p = 0.03 vs. 86.8→ 94.6 %, p < 0.001;
NS). Overall, 53.8 and 52.4 % of patients were deemed to
be treatment ‘responders’ (NS).
Perhaps most alarming of these results are those of
the survival study [118], in which 1339 out of 18,754 pa-
tients on CPAP died over the course of observation
(7.1 %) versus just 71 of 2072 (3.4 %) post-operatively.
Adjusting for patient age, gender, race, year of treatment
and co-morbid illnesses, there still was a 31 % (95 % CI:
3–67 %) increase in mortality among CPAP patients
(p = 0.03) versus their post-UPPP counterparts. It may be
that some patients receiving CPAP were considered too ill
to be surgical candidates, a confounder that would falsely
elevate the CPAP mortality rate. It is also important to ac-
knowledge that the study authors were not able to adjust
for OSA severity or account for CPAP adherence. None-
theless, it is clear that all prior assumptions that CPAP is
both more effective and safer than surgery as first-line
treatment for OSA warrant re-evaluation.
In summary, though it is true that the evidence sup-
porting CPAP over surgery as first-line therapy for OSA
is more strongly supported by EBM level 1 evidence,
closer inspection reveals major limitations of that evi-
dence and reasons to suspect that this long-held as-
sumption should now be questioned. Among these
limitations are the very short-term follow-up of almost
all CPAP trials (versus the longer follow-up of surgical
trials); the very high degree of CPAP non-adherence
that, in the vast majority of trials, was not accounted for
by intent-to-treat analysis; failure to identify any signifi-
cant advantage of CPAP over surgery in the two trials in
which these two approaches were compared directly;
and the apparent 30 % increased mortality observed in
veterans who received CPAP versus surgical treatment
in the U.S. between 1997 and 2001. Surgery appears to
be clinically successful long-term in at least half of OSA
patients, in terms of reducing their AHI to normal or
near-normal levels. Given all of this, the time has come
to rethink our CPAP-first approach to the OSA patient,
especially in those patients in whom adherence, for
whatever reason, might be considered an issue. Within
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that context however it is also imperative that surgeons
understand that changing the current care ladder means
also stressing the importance of correct patient selection
and an appropriate consent process.
As a systematic review, this study is limited to the
quality of the included studies. Because it is a collection
of findings from various other studies, it provides an
overview of the direction of literature but is unable to
show new findings. This study is also limited in the fact
that only English language articles are considered, which
may introduce a language bias. However, studies are
published from a variety of centers internationally. Be-
cause this study is not a meta-analysis, study results have
not been statistically combined for more powerful re-
sults. One additional caveat is that studies were only
graded by a traditional EBM approach as opposed to the
more sophisticated Cochrane GRADE tool. This may
introduce some level of bias to the priorities given to the
various studies. However the large volume of literature
reviewed for this paper should adequately compensate
for that.
Conclusion
This review illustrates the need for an in-depth, thor-
ough and critical analysis of the available treatment op-
tions for the OSA patient. Although CPAP is often
documented as the gold standard or mandatory first line
therapy for patients with OSA, a careful assessment of
the outcomes provided by the literature does not sup-
port this assertion, especially when the concept of CPAP
adherence is taken into account. Clinicians should con-
sider a patient-centered approach to care wherein the
patient’s individual anatomical characteristics are evalu-
ated in context of their OSA severity and treatment
goals, and then tailor intervention to individual needs.
In many patients beneficial surgical results may supplant
the role of the CPAP machine when considering first
line therapy.
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